Skip to content

What impact does double filtration plasmaphresis therapy have on the prognosis of transplanted kidneys in patients with antibody-mediated rejection

The impact of double filtration plasmaphresis on the survival rate of transplanted kidneys in patients with antibody-mediated rejection

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129334
Enrollment
Unknown
Registered
2026-08-03
Start date
2025-05-24
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antibody-mediated rejection after kidney transplantation

Interventions

control group:None
DFPP treatment group:None

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.All the outpatients who follow-up in our hospital after kidney transplantation and diagnosed with ABMR (DSA antibody positive + Banff classification diagnosis of ABMR or mixed rejection);

Exclusion criteria

Exclusion criteria: 1.Factors such as severe infections, coagulation dysfunction, and biopsy contraindications were taken into account to exclude any potential interference with the study results.

Design outcomes

Primary

MeasureTime frame
Donar specific antibody, serum creatinine;

Secondary

MeasureTime frame
Pathology of the transplanted kidney;Blood coagulation routine test, humoral immunity;Urinary proteinor urinary albumin/creatine;

Countries

China

Contacts

Public ContactYing Yin

The First Affiliated Hospital of Soochow University

yinyingcici@163.com+86 512 67973374

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026